TD Securities raised the stock price target for The Descartes Systems Group (OTC:KXSCF) from $130 to $165. The brokerage gave the stock a Buy rating. KXSCF stock closed at $105.31 on May 5.
Morgan Stanley lowered the stock price target for AMC Networks (NASDAQ:AMCX) from $47 to $27. The brokerage gave the stock an Equal Weight rating. AMCX stock closed at $22.87 on May 5.
JPMorgan Chase lowered the stock price target for Glaukos (NYSE:GKOS) from $55 to $40. The brokerage gave the stock a Neutral rating. GKOS stock closed at $38.44 on May 5.
Royal Bank of Canada lowered the stock price target for Colliers International Group (NASDAQ:CIGI) from $94 to $80. The brokerage gave the stock an Outperform rating. CIGI stock closed at $50.12 on May 5.
Seaport Global Securities lowered the stock price target for Par Pacific (NYSEAMERICAN:PARR) from $29 to $15. The brokerage gave the stock a Buy rating. PARR stock closed at $9.75 on May 5.
Roth Capital lowered the stock price target for Insperity (NYSE:NSP) from $97 to $85. The brokerage gave the stock a Buy rating. NSP stock closed at $53 on May 5.
Barclays lowered the stock price target for Shake Shack (NYSE:SHAK) from $60 to $49. SHAK stock closed at $49.22 on May 5.
Guggenheim lowered the stock price target for Kontoor Brands (NYSE:KPTI) from $40 to $30. The brokerage gave the stock an Outperform rating. KPTI stock closed at $19.63 on May 5.
Nomura lowered the stock price target for Hilton Grand Vacations (NYSE:HGV) from $33 to $23. The brokerage gave the stock a Neutral rating. HGV stock closed at $17.53 on May 5.
Maxim Group raised the stock price target for Applied DNA Sciences (NASDAQ:APDN) from $8 to $18. The brokerage gave the stock a Buy rating. APDN stock closed at $8.61 on May 5.
Last week, we profiled some of the biggest potential penny stock gainers for the month of May. While many of those picks have already taken off, there are still plenty of stocks left to discuss. ... [Read]
Major stock markets saw a sharp dip Wednesday after investors were handed a dose of reality on the COVID-19 pandemic, but there were still a handful of penny stock gainers that are worth watching this ... [Read]
Jefferies Financial Group raised the stock price target for Methanex (NASDAQ:MEOH) from $13 to $36. The brokerage upgraded the stock from a Hold rating to a Buy rating. MEOH stock closed at $15.88 on May ... [Read]
SunTrust Banks lowered the stock price target for Ryman Hospitality Properties (NYSE:RHP) from $82 to $26. The brokerage gave the stock a Hold rating. RHP stock closed at $37.78 on April 29. SunTrust Banks lowered ... [Read]
HC Wainwright raised the stock price target for Arcturus Therapeutics (NASDAQ:ARCT) from $26 to $62. The brokerage gave the stock a Buy rating. ARCT stock closed at $30.53 on April 28. Wells Fargo lowered the ... [Read]
Wells Fargo lowered the stock price target for Brinker International (NYSE:EAT) from $48 to $17. The brokerage gave the stock an Equal Weight rating. EAT stock closed at $17.15 on April 27. Jefferies Financial Group ... [Read]
DA Davidson lowered the stock price target for Weight Watchers International (NASDAQ:WW) from $63 to $38. The brokerage gave the stock a Buy rating. WW stock closed at $20.58 on April 24. Stifel Nicolaus lowered ... [Read]
JPMorgan Chase lowered the stock price target for CONMED (NASDAQ:CNMD) from $136 to $76. The brokerage gave the stock an Overweight rating. CNMD stock closed at $65.64 on April 23. BMO Capital Markets lowered the ... [Read]
Canaccord Genuity lowered the stock price target for Canadian Tire (OTCPK:CDNAF) from $160 to $108. The brokerage gave the stock a Hold rating. CDNAF stock closed at $66.83 on April 22. Jefferies Financial Group raised ... [Read]
Risks and Disclosure:
Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.
All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.
This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.
Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Please see our full disclaimer here for additional details before making any investment decisions.
